GRDNThe company shows solid fundamental performance and positive thematic alignment, but current technical indicators suggest a need for caution due to potential overbought conditions. Long-term prospects appear favorable.
Guardian Pharmacy Services operates in the healthcare sector, with a focus on long-term care pharmacy services. The company's growth is tied to demographic trends in aging populations and the increasing demand for specialized pharmacy care.
Guardian Pharmacy Services demonstrates improving revenue and profitability over recent years, with a manageable debt level and positive free cash flow. However, recent quarterly performance shows a significant dip in net income.
The stock is trading below key moving averages on a daily basis, indicating a bearish short-term trend. While some shorter timeframes show neutral or buy signals, the overall trend suggests caution.
| Factor | Score |
|---|---|
| Healthcare Demographics | 75 |
| Pharmacy Services Market | 70 |
| Technological Integration | 70 |
| Regulatory Landscape | 65 |
| Factor | Score |
|---|---|
| Valuation | 40 |
| Profitability | 35 |
| Growth | 80 |
| Balance Sheet Health | 85 |
| Cash Flow | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 50 |
| Support & Resistance | 65 |
| Short-term Oscillators | 75 |
| Short-term Moving Averages | 75 |
Strengthening Debt Position
Total debt decreased from $61.00M in Q4 2023 to $30.13M in Q4 2024, indicating a significant deleveraging effort and improved financial stability. The debt-to-equity ratio has improved, suggesting lower financial risk.
Revenue Growth Trend
Revenue has shown an upward trend, growing from $792.07M in 2021 to $1.23B in 2024, demonstrating consistent top-line expansion.
Negative Net Income
The company reported a net loss of -$87.29M in 2024, indicating a lack of profitability. This is a significant concern for investors.
Declining Net Margin
The net margin has turned negative (-7.1% in 2024), compared to a positive 2.3% in 2023, signaling a deterioration in profitability and operational efficiency.
August 2025
8
Next Earnings Date
H: $0.22
A: $0.21
L: $0.21
H: 329.70M
A: 329.57M
L: 329.44M
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
27.33 USD
The 39 analysts offering 1 year price forecasts for GRDN have a max estimate of 28.00 and a min estimate of 26.00.